Epogen :: Science Biology Papers

EpogenEpogen is produced by the company Amgen. Amgen located atThousand Oaks, California, is a global biotechnology company. It discovers, develops, manufactures, and markets human therapeutics based on advanced cellular and molecular biology. Amgen, founded in 1980, is now the largest biotechnology company in the world. It has 4,200 employers almost the world and 2,700 of the 4,200 workers, work at the headquarters in Thousand Oaks. Amgen has centers of explore in Boulder, Colorado and Toronto, Canada clinical research centers in Cambridge, England and Melbourne, Australia the international distribution center in Louisville, Kentucky, fill and finish facility in Junco, Puerto anti-racketeering law and European regional headquarters in Lucerne, Switzerland. Amgen has other international offices that argon located in Austria, Australin, Belgium, Canada, China, France, Germany, Italy, Japan, the Netherlands, Hong Kong, Portugal, Spain, and the United Kingdom. (Amgen 1996)Amgens firs t product, Epogen was approved in June 1989 for use up in the United States. Neupogen (filgrastim) Amgens second product, received approval for use in February 1991, is use for preventing infections in cancer patients that receive chemotherapy for bone marrow and computer peripheral air progenitor cell transplantation patients and treatment for chronic neutropenia, which is a rare blood disorder. Amgen has research in the areas of hematopoiesis, neurobiology, inflammation/autoimmunity, and soft wander repair and regeneration. Products from the research, in the four areas mentioned from above, may, sometime in the future, be used in treating conditions characterized by disorders of blood and bone marrow, neurodegenerative diseases such as ALS, Parkinsons, Alzheimers, or traumatic nerve injury.EpogenEpoetin Alfa recombinant Epogen, or Epogen, has 3,000 units of recombinant Epoetin Alfa, 2.5 mg Albumin (Human) in sterile buffered solution (pH 6.9 +/- 0.3) of sodium citrate (5.8mg), sodium chloride (5.8mg), citric acid (0.06mg), in Water for injection.Its uses are stimulating the body to make red blood cells, treatments of anemia (loss or reduction of red blood cells) associated with chronic renal failure or anemia caused by AZT (zidovudine) in HIV-infected persons. beforehand Epogen was produced or used, blood transfusions and male hormone therapy was used in treating anemia, which was caused by chronic renal failure. Epogen StudiesStudies on Epogen are available from Amgen, Food and dose Administration (FDA), and the Journal of the American Society of Nephrology. One acquire by Amgen was to establish the safety and efficacy of EPOGEN in pediatric patients (Amgen 89), the second study from FDA, was about erythropoietin, which is